Heligenics

Las Vegas, NV · Founded 2015 · Privately Held (backing)

Developer of a medicinal drug designed to prevent disease and heal patients afflicted with illness through genomics. Heligenics is based in Las Vegas, NV and was founded in 2015. Its last reported valuation was $17.2 million in Aug 2022. It has raised $6 million across 3 recorded rounds; the latest was a $2.6 million seed round in Aug 2024.

Last reported valuation
$17.2M
Oct 2026
Priced at
—
Total raised
$6.0M
Last round
Seed Round
Aug 2024
How much has Heligenics raised?
$6.0Macross 3 recorded rounds · Mar 2020 – Aug 2024

Most recently, Heligenics raised $2.6M in its Seed Round (Aug 2024).

Free account
More of Heligenics with a free account
  • ·Watch Heligenics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Heligenics round by round

3 rounds
Aug 2024Seed Round$2.6MSEC filing▮
8 investors participated
Jun 2022Seed Round$2.2MSEC filing▮
12 investors participated
Mar 2020Seed Round$1.2MSEC filing▮
39 investors participated

How much has Heligenics raised?

Heligenics has raised $6 million across 3 recorded rounds since 2020. The largest was a $2.6 million seed round in Aug 2024.

Heligenics has filed 3 Form Ds with the SEC since 2020, most recently in Jan 2025 ($2.6 million sold to 8 investors).

Heligenics investors

5 investors are on record for Heligenics, including Battle Born Venture, City of Las Vegas, Las Vegas Foundation and Nevada Governor's Office of Economic Development. The seed round in Aug 2024 drew 8 investors.

For fundraisers
Raising for a company like Heligenics?

5 investors have backed Heligenics.

See all 5 investors →

Frequently asked about Heligenics

How much has Heligenics raised?
Heligenics has raised $6.0M in total across 3 recorded funding rounds.
When was Heligenics's last funding round?
Heligenics's most recent recorded round was Seed Round in Aug 2024, raising $2.6M.